Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.'s latest marketcap:
As of 07/16/2025, Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.'s market capitalization has reached $59.59 M. According to our data, Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is the 28560th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 59.59 M |
| Revenue (ttm) | 13.36 M |
| Net Income (ttm) | -5,990,482.47 |
| Shares Out | 220 M |
| EPS (ttm) | -0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2025 |
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.'s yearly market capitalization.
| Date | Market Cap(₺) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/16/2025 | ₺2.4 B | $59.59 M | -11.81% | 28560 |
| 12/31/2024 | ₺2.72 B | $75.51 M | -0.72% | 25141 |
| 12/29/2023 | ₺2.74 B | $91.81 M | -42.23% | 23644 |
| 12/30/2022 | ₺4.74 B | $251.04 M | 47.6% | 16685 |
| 12/31/2021 | ₺3.21 B | $240.58 M | 17764 |
Company Profile
About Anatolia Tani ve Biyoteknoloji Ürünleri
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is a leading biotechnology company based in Istanbul, Turkey. The company specializes in the design, development, and manufacturing of advanced diagnostic solutions, including real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments.
Product Offerings
- Diagnostic Kits: Microbiology, genetic disorder, panel, sequencing, and food testing kits.
- Nucleic Acid Extraction Solutions: Manual spin column and magnetic bead nucleic acid extraction kits.
- Automated Instruments: Automated nucleic acid (NA) extraction instrument kits.
Disease Coverage
The company provides diagnostic products for a wide range of diseases, including:
- Brucellosis, Chlamydia trachomatis, Cytomegalovirus
- Crimean-Congo Hemorrhagic Fever, COVID-19 (SARS-CoV-2)
- Epstein-Barr Virus, Hepatitis B, C, and D
- Herpes Simplex Virus, HIV, Human Papillomavirus
- JC and BK Polyomaviruses, Malaria, Measles
- Meningitis, Respiratory Infections, Parvovirus B19
- Torque Teno Virus, Toxoplasmosis, Tuberculosis
- Ureaplasma, West Nile Virus
- Genetic Disorders: Factor II, Factor V Leiden, MTHFR mutations
With its headquarters in Istanbul, Anatolia Tani ve Biyoteknoloji continues to innovate in the biotechnology sector, delivering high-quality diagnostic solutions for healthcare and research.
Frequently Asked Questions
-
What is Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.'s (IST-ANGEN) current market cap?As of 07/16/2025, Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (including the parent company, if applicable) has an estimated market capitalization of $59.59 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST-ANGEN) rank globally by market cap?Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. global market capitalization ranking is approximately 28560 as of 07/16/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.